Crossmark

Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery

Crossref DOI link: https://doi.org/10.1007/s00270-022-03259-z

Published Online: 2022-09-04

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deloose, Koen https://orcid.org/0000-0001-5434-7323
Lansink, Wouter

Brodmann, Marianne

Werner, Martin

Keirse, Koen

Gouëffic, Yann

Verbist, Jürgen

Maene, Lieven

Hendriks, Jeroen

Brunet, Jerome

Ducasse, Eric

Levent, Kara

Sauguet, Antoine

Déglise, Sébastien

Vandael, Femke
Funding

Funding for this research was provided by:

Biotronik
License Information

Text and Data Mining valid from 2022-09-04

Version of Record valid from 2022-09-04
More Information

Article History

Received: 6 September 2021

Accepted: 10 August 2022

First Online: 4 September 2022

Declarations

:

: Dr. Deloose has received research grants from BIOTRONIK.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: Consent for publication was obtained for every individual person’s data included in the study.

Document is current

Any future updates will be listed below